Comparison of alpha–theta neurofeedback versus sensorimotor rhythm neurofeedback in the treatment of patients with fibromyalgia: A randomized, double-blind, controlled clinical trial
DOI:
https://doi.org/10.22122/cdj.v8i3.523Keywords:
Neurofeedback, Fibromyalgia, PainAbstract
BACKGROUND: Fibromyalgia (FM) is a chronic disease with widespread musculoskeletal pain. In this study, we used neurofeedback to reduce pain and enhance the quality of life (QOL).
METHODS: We conducted a double-blind randomized controlled trial (RCT) in 40 patients referred to Tuba Specialized Clinic and Clinic of Imam Khomeini Hospital in Sari, Iran, between December 2013 and July 2015. Group 1 underwent sensorimotor rhythm (SMR) neurofeedback training and group 2 underwent neurofeedback training for alpha-theta training. The primary outcomes were pain reduction and increasing QOL, which were measured using Visual Analog Scale (VAS), Numeric Pain Scale, Fibromyalgia Impact Questionnaire (FIQ), and Medical Outcomes Study (MOS) Sleep Scale, respectively, within the first day, 4 weeks, and 8 weeks post-randomization.
RESULTS: A total of 46 patients were screened for eligibility and 40 patients completed the trial. In both groups, the differences between FIQ scores before and after the study were statistically significant (P < 0.05).
CONCLUSION: Neurofeedback training could be applied to reduce pain and improve the QOL of patients with FM.
References
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62(5): 600-10.
Stisi S, Cazzola M, Buskila D, Spath M, Giamberardino MA, Sarzi-Puttini P, et al. Etiopathogenetic mechanisms of fibromyalgia syndrome. Reumatismo 2008; 60(Suppl 1): 25-35.
Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013; 17(8): 356.
Kristevski AA. Neurofeedback for fibromyalgia. The Chicago School of Professional Psychology 2020; 111: 3637158.
Kravitz HM, Esty ML, Katz RS, Fawcett J. Treatment of fibromyalgia syndrome using
low-intensity neurofeedback with the flexyx neurotherapy system: A randomized controlled clinical trial. J Neuro 2006; 10(2-3): 41-58.
Kayiran S, Dursun E, Dursun N, Ermutlu N, Karamursel S. Neurofeedback intervention in fibromyalgia syndrome; A randomized, controlled, rater blind clinical trial. Appl Psychophysiol
Biofeedback 2010; 35(4): 293-302.
Caro XJ, Winter EF. EEG biofeedback treatment improves certain attention and somatic symptoms in fibromyalgia: A pilot study. Appl Psychophysiol Biofeedback 2011; 36(3): 193-200.
Kayiran S, Dursun E, Ermutlu N, Dursun N, Karamursel S. Neurofeedback in fibromyalgia syndrome. Agri 2007; 19(3): 47-53.
Gruzelier J. A theory of alpha/theta neurofeedback, creative performance enhancement, long distance functional connectivity and psychological integration. Cogn Process 2009; 10(Suppl 1): S101-S109.
Cortoos A, De Valck E, Arns M, Breteler MH, Cluydts R. An exploratory study on the effects of tele-neurofeedback and tele-biofeedback on objective and subjective sleep in patients with primary insomnia. Appl Psychophysiol Biofeedback 2010; 35(2): 125-34.
Russo GM, Novian DA. A research analysis of neurofeedback protocols for PTSD and alcoholism. NeuroRegulation 2014; 1(2): 183.
Dadashi M, Birashk B, Taremian F, Asgarnejad AA, Momtazi S. Effects of increase in amplitude of occipital alpha & theta brain waves on global functioning level of patients with GAD. Basic Clin Neurosci 2015; 6(1): 14-20.
Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT Diagnostic Criteria for Fibromyalgia. J Pain 2019; 20(6): 611-28.
Bernik M, Sampaio TP, Gandarela L. Fibromyalgia comorbid with anxiety disorders and depression: Combined medical and psychological treatment. Curr Pain Headache Rep 2013; 17(9): 358.
Sanada K, Diez MA, Valero MS, Perez-Yus MC, Demarzo MM, Garcia-Toro M, et al. Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: A systematic review. Arthritis Res Ther 2015; 17: 272.
Thompson M. The neurofeedback book: An introduction to basic concepts in applied psychophysiology. Wheat Ridge, CO: Association for Applied Psychophysiology and Biofeedback; 2003.
Bidari A, Hassanzadeh M, Mohabat MF, Talachian E, Khoei EM. Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P). Rheumatol Int 2014; 34(2): 181-9.
Harris ED. Kelley's textbook of rheumatology. Philadelphia, PA: Elsevier Saunders; 2005.
Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23(5 Suppl 39): S154-S162.
Wolfe F, Michaud K, Li T. Sleep disturbance in patients with rheumatoid arthritis: Evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol 2006; 33(10): 1942-51.
Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005; 6(1): 41-4.
Martin S, Chandran A, Zografos L, Zlateva G. Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes 2009; 7: 64.
Montazeri A, Vahdaninia M, Mousavi SJ, Asadi-Lari M, Omidvari S, Tavousi M. The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): A population-based validation study from Tehran, Iran. Health Qual Life Outcomes 2011; 9: 12.
Ibric VL, Dragomirescu LG. Neurofeedback in pain management. In: Budzynski TH, Budzynski HK, Evans JR, Abarbanel A, Editors. Introduction to quantitative EEG and neurofeedback: advanced theory and applications. San Diego, CA: Academic Press; 2009.
Santoro M, Cronan T. A systematic review of neurofeedback as a treatment for fibromyalgia syndrome symptoms. J Musculoskelet Pain 2014; 22(3): 286-300.
Nelson DV, Bennett RM, Barkhuizen A, Sexton GJ, Jones KD, Esty ML, et al. Neurotherapy of fibromyalgia? Pain Med 2010; 11(6): 912-9.
